adamantane has been researched along with Breast Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Dey, P; Katzenellenbogen, BS; Katzenellenbogen, JA; Kim, SH; Laws, MJ; Nelson, ER; Nettles, KW; Park, BH; Shahoei, SH; Yasuda, M; Ziegler, Y | 1 |
| Chen, H; Chen, J; Jiang, B; Kuang, Y; Li, C; Liao, T; Liu, C; Ren, J; Sun, Z | 1 |
| Abdel-Samad, R; Aouad, P; Darwiche, N; El-Houjeiri, L; Fostok, S; Pisano, C; Saikali, M; Talhouk, R | 1 |
| Carlson, KE; Gong, P; Guillen, VS; Katzenellenbogen, BS; Katzenellenbogen, JA; Kim, SH; Mayne, CG; Min, J; Nettles, KW; Sharma, A; Srinivasan, S; Zhao, Y; Ziegler, Y | 1 |
| Chen, H; Lim, WQ; Phua, SZF; Thanabalu, T; Verma, A; Yang, G; Zhao, Y | 1 |
| Chen, JT; Chen, Y; Liu, Y; Yang, Y; Zhang, YM | 1 |
| Han, HK; Lee, EH; Lee, K; Lee, YS; Lim, SJ; Park, JA; Song, JG; Yang, SJ; Zhao, M | 1 |
| Cai, Y; Seeberger, PH; Wang, S; Wang, XJ; Xu, JL; Ye, Z; Yin, J; Zhang, Q | 1 |
| Antoon, JW; Beckman, BS; Burow, ME; Driver, JL; Elliott, S; Khalili, HS; Slaughter, EM; Smith, CD; White, MD | 1 |
| Antoon, JW; Beckman, BS; Burow, ME; Driver, JL; White, MD | 1 |
| Dawson, MI; Farhana, L; Fontana, JA; Freeman, RS; Huang, Y; Reddy, KB; Rishi, AK; Zhang, Y | 1 |
| Blishchenko, EY; Ivanov, VT; Kalinina, OA; Karelin, AA; Moiseeva, EV; Sazonova, OV; Vass, AA | 1 |
| Dawson, MI; Farhana, L; Fontana, JA | 1 |
13 other study(ies) available for adamantane and Breast Neoplasms
| Article | Year |
|---|---|
Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors.
Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Estrogen Receptor Modulators; Female; Humans; Ketones; Liver Neoplasms; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Receptors, Estrogen; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a "tumor-triggered targeting" property.
Topics: Adamantane; Animals; Antibiotics, Antineoplastic; Benzimidazoles; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Compounding; Female; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Nanoparticles; Oligopeptides; Polyethylene Glycols; Porosity; Silicates; Tumor Burden | 2021 |
Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models.
Topics: Adamantane; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cinnamates; Female; Humans; MCF-7 Cells; Triple Negative Breast Neoplasms | 2017 |
Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells.
Topics: Acrylamides; Adamantane; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Screening Assays, Antitumor; Esters; Estrogen Antagonists; Estrogen Receptor alpha; Female; Humans; Ketones; Radioligand Assay; Stereoisomerism; Structure-Activity Relationship | 2017 |
Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor.
Topics: Adamantane; Animals; Breast Neoplasms; Catalase; Cell Line, Tumor; Chlorophyllides; Female; Humans; Hyaluronic Acid; Mice, Nude; Nanocapsules; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2019 |
Targeted polysaccharide nanoparticle for adamplatin prodrug delivery.
Topics: Adamantane; Animals; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Cyclodextrins; Drug Carriers; Drug Delivery Systems; Female; Humans; Hyaluronic Acid; Hydrophobic and Hydrophilic Interactions; Mice; Nanoparticles; NIH 3T3 Cells; Organoplatinum Compounds; Prodrugs | 2013 |
Discovery of LW6 as a new potent inhibitor of breast cancer resistance protein.
Topics: Acetanilides; Adamantane; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Discovery; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Proteins; Rats; Rats, Sprague-Dawley | 2016 |
Targeted Photodynamic Killing of Breast Cancer Cells Employing Heptamannosylated β-Cyclodextrin-Mediated Nanoparticle Formation of an Adamantane-Functionalized BODIPY Photosensitizer.
Topics: Adamantane; beta-Cyclodextrins; Boron Compounds; Breast Neoplasms; Cell Death; Humans; Nanoparticles; Photochemotherapy; Photosensitizing Agents | 2016 |
Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Mice; Mice, SCID; Molecular Targeted Therapy; NF-kappaB-Inducing Kinase; Phosphotransferases (Alcohol Group Acceptor); Protein Serine-Threonine Kinases; Pyridines; Receptors, Estrogen; Signal Transduction; Xenograft Model Antitumor Assays | 2011 |
Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.
Topics: Adamantane; Aminophenols; Animals; Antineoplastic Agents, Hormonal; Base Sequence; Breast Neoplasms; Cell Line, Tumor; DNA Primers; Drug Resistance, Neoplasm; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Isoenzymes; Mice; Mice, Nude; Mice, SCID; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Thiazoles; Xenograft Model Antitumor Assays | 2012 |
Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities.
Topics: Adamantane; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cinnamates; ErbB Receptors; Female; Humans; Male; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Recombinant Proteins; Transfection | 2004 |
Antitumor effect of valorphin in vitro and in vivo: combined action with cytostatic drugs.
Topics: Adamantane; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bone Marrow Cells; Breast Neoplasms; Carcinoma; Cell Proliferation; Drug Interactions; Epirubicin; Fibroblasts; Humans; Mice; Mice, Inbred BALB C; Survival; Tumor Cells, Cultured; Vincristine | 2005 |
Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation.
Topics: 3T3 Cells; Adamantane; Animals; Apoptosis; bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Cinnamates; fas Receptor; Humans; I-kappa B Proteins; Male; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Prostatic Neoplasms; Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; RNA, Messenger; Transcription Factor RelA; X-Linked Inhibitor of Apoptosis Protein | 2005 |